Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Allergic Reactions02:06

Allergic Reactions

33.6K
Overview
33.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D status and <i>Helicobacter pylori</i> infection: clinical associations and lipid pathway differences in an exploratory metabolomics sub-study.

Frontiers in nutrition·2026
Same author

SPPIDER-seq: Sequence-based Partner-aware Predictor of Protein-Protein Interaction Sites.

Bioinformatics (Oxford, England)·2026
Same author

Inhaled pattern recognition receptor agonists promote inducible epithelial resistance against murine betacoronavirus disease.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Design, synthesis, and anti-inflammatory evaluation of novel analogues derived from the natural product reticuline.

Journal of enzyme inhibition and medicinal chemistry·2026
Same author

Integrated in vitro and in vivo evaluation of ivermectin hydrogel formulation for management of scabies with pharmacological assessment.

Scientific reports·2026
Same author

Wastewater-Based Surveillance of SARS-CoV-2 for Early Warning of COVID-19 Infection Dynamics.

Viruses·2026
Same journal

Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme.

European journal of immunology·2026
Same journal

Generation of Regulatory T Cells Against Islet Neoantigen.

European journal of immunology·2026
Same journal

Complement Inhibition in the Clinic: Are We Doing Enough to Protect Patients From Infection?

European journal of immunology·2026
Same journal

Special Issue: yEFIS 3rd Symposium.

European journal of immunology·2026
Same journal

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026
Same journal

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

European journal of immunology·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.3K

Prophylactic Inhaled Pattern Recognition Receptor Agonists Reprogram Lung Epithelial Response and Prevent Type 2

Mbaya Ntita1, Celine Shuet Lin Kong1, Dalia Hassan2

  • 1Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

European Journal of Immunology
|March 27, 2026
PubMed
Summary
This summary is machine-generated.

Prophylactic inhalation of Pam2ODN prevents allergic lung disease by reprogramming lung cells. This approach reduces inflammation and maintains protective immune cells, offering a new strategy for chronic allergic conditions.

Keywords:
PRR agonistsType 2 allergylung epithelial cellreprogramming

More Related Videos

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.9K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

23.6K

Related Experiment Videos

Last Updated: Mar 29, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.3K
Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.9K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

23.6K

Area of Science:

  • Immunology
  • Pulmonology
  • Allergy Research

Background:

  • Allergic lung diseases, such as those induced by house dust mite (HDM), involve complex immune responses in the airways.
  • Current treatments aim to manage symptoms, but preventing sensitization and underlying inflammation remains a key challenge.
  • The precise mechanisms by which prophylactic treatments modulate lung immune cell interactions to prevent allergic inflammation are not fully understood.

Purpose of the Study:

  • To elucidate the immunomodulatory effects of inhaled ODN M362 and Pam2CSK4 (Pam2ODN) on lung cells and immune responses in a mouse model of allergic lung disease.
  • To investigate how Pam2ODN pretreatment influences dendritic cell (DC) populations and T helper cell polarization following house dust mite (HDM) sensitization.
  • To determine the impact of Pam2ODN on gene expression and chromatin accessibility in lung epithelial cells.

Main Methods:

  • Mice were prophylactically treated with inhaled Pam2ODN before sensitization with house dust mite (HDM).
  • Immune cell populations (dendritic cells, T cells) in the lungs were analyzed using flow cytometry.
  • Bulk and single-cell RNA sequencing (RNA-seq) were performed on whole lung tissue and isolated lung epithelial cells.
  • Analysis of gene expression, inflammatory pathways, and chromatin accessibility was conducted.

Main Results:

  • Pam2ODN inhalation before HDM sensitization suppressed airway Th2 polarization without altering Th1 or regulatory T cell (Treg) responses.
  • Pretreatment with Pam2ODN inhibited the recruitment of monocyte-derived dendritic cells (moDCs) and conventional Type 2 dendritic cells (DC2s).
  • Pam2ODN prevented the HDM-induced reduction in conventional Type 1 dendritic cells (DC1s) and restricted the expression of pro-inflammatory transcripts in the lung.
  • Single-cell analysis revealed that Pam2ODN attenuated pro-inflammatory pathways and chromatin accessibility in lung epithelial cells.

Conclusions:

  • Inhaled Pam2ODN reprograms lung epithelial cells to reduce the production of Th2-promoting cytokines in response to allergens.
  • Pam2ODN effectively modulates dendritic cell populations, preserving protective DC1s while limiting inflammatory DC recruitment.
  • These findings support Pam2ODN as a potential prophylactic strategy to mitigate chronic allergic lung diseases by establishing immune tolerance.